98%
921
2 minutes
20
Introduction: Pediatric cholesteatoma is an aggressive disease which requires long-term evaluation to assess management strategies. The objective was to determine optimal follow-up duration in pediatric cholesteatoma to detect residual and recurrent diseases.
Methods: This cohort study was set in a tertiary referral center. All consecutive patients with a minimum 5-year follow-up were included. Medical history, initial extension, surgical procedures, and follow-up were collected. The main outcome measure were Kaplan-Meier survival curves of residual and recurrence cumulative incidence.
Results: Totally 239 ears with the first tympanoplasty between 2008 and 2014 were studied including 25% congenital. At first surgery (S1), mean age was 8.4 years and mean follow-up time 7.9 years. Mastoidectomy was performed in 69% and stapes was absent in 38% of cases. Notably, 83% (199 ears) had a second procedure (S2) of which 186 were planned. After S1, maximum cumulated incidence of residual was 45% [95%CI, 38%; 52%] at 74 months, with probability of residual of 39% at 3 years. After S2 (n = 199), maximum cumulated residual incidence was 21% [95%CI, 12%; 32%] at 62 months and 16% at 3 years. Concerning recurrence, maximum cumulated incidence after S1 (n = 239) was reached at 98 months with 21% [95%CI, 12%; 32%], 13% at 3 years and 16% at 5 years. Congenital disease had significantly less residuals after S1 (p = 0.02), but similar recurrence rate (p = 0.66) compared with acquired.
Conclusions And Relevance: We recommend MRI follow-up of at least 5 years after the last surgery for residual disease and clinical follow-up of at least 10 years to detect recurrence.
Level Of Evidence: 4 Laryngoscope, 134:4789-4798, 2024.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/lary.31567 | DOI Listing |
Auris Nasus Larynx
September 2025
Department of Otolaryngology, Deafness and Middle Ear Surgicenter Tokyo Kita Medical Center, 4-17-56 Akabanedai, Kita-ku, Tokyo 115-0053, Japan; Department of Otolaryngology, Head and Neck Surgery, Jichi University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-0834, Japan.
Objective: This study aimed to evaluate the effect of age at tympanostomy tube insertion on mastoid air cell development, focusing on whether insertion before 3 years of age is associated with more favorable pneumatization.
Methods: We retrospectively analyzed 39 children (71 ears) who developed tympanic membrane perforation following tube insertion (tube group), including cases primarily associated with recurrent acute otitis media (rAOM) and otitis media with effusion (OME). The control group consisted of 41 children (41 ears) with congenital cholesteatoma, using their contralateral normal ears as controls.
Int J Surg Case Rep
September 2025
Department of Otolaryngology, Yusuf al-Azma Hospital, Military Service Administration (MSA) research center, G763+J9M, Damascus, Syria.
Introduction: Congenital cholesteatoma is a rare, benign lesion characterized by the presence of keratinizing squamous epithelium in the middle ear without a history of infection, tympanic membrane perforation, or prior ear surgery. It often remains asymptomatic until it causes hearing loss or is incidentally detected during an otologic examination.
Case Presentation: We report the case of a 4-year-old boy who presented to the ENT clinic with suspected hearing impairment.
Otolaryngol Pol
July 2025
Department of Otolaryngology-Head and Neck Surgery, Medical University of Lublin, Poland.
<b>Introduction:</b> Vestibular schwannoma (VS) is the most common cerebellopontinetumor, causing sensorineural hearing loss, tinnitus, and vertigo. Chronic otitis mediawith cholesteatoma presents with recurrent ear discharge and hearing loss, typicallyrequiring surgical intervention. Although the coexistence of VS and cholesteatoma israre, it creates complex diagnostic and therapeutic challenges that necessitate individualized management approaches.
View Article and Find Full Text PDFInt J Pediatr Otorhinolaryngol
September 2025
Department of Otolaryngology, Istanbul Medipol University Health Care Practice and Research Center Esenler Hospital, Istanbul, Turkey. Electronic address:
Aim: To compare hearing outcomes and prognostic factors in pediatric patients undergoing ossiculoplasty with autologous incus interposition (AII) or total ossicular replacement prosthesis (TORP).
Methods: This retrospective study included 102 children under 18 who underwent tympanoplasty with ossicular reconstruction between 2021 and 2024. Patients were divided into two groups based on reconstruction type (AII or TORP).
Braz J Otorhinolaryngol
July 2025
Capital Medical University, Beijing Children's Hospital, National Center for Children's Health, National Key Clinical Specialty, Department of Otorhinolaryngology Head and Neck Surgery, Beijing, China; Beijing Key Laboratory for Pediatric Diseases of Otolaryngology Head and Neck Surgery, Beijing, Ch
Objectives: To analyze the clinical characteristics of bilateral cholesteatoma in children and summarize the clinical treatment pathway.
Methods: In this retrospective cohort study, we analyzed the records of children with bilateral middle ear cholesteatoma who underwent surgery in our department between 2016 and 2023. The clinical characteristics, treatment and prognosis were analyzed.